Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariella Kelman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Rheumatology Reports|January 10, 2004
Outcome measures in osteoarthritis: randomized controlled trialsVibeke Strand, Ariella Kelman
Best Practice & Research. Clinical Rheumatology|November 23, 2005
The management of secondary osteoporosisAriella Kelman, Nancy E Lane
Arthritis Research & Therapy|August 23, 2003
A review of anabolic therapies for osteoporosisNancy E Lane, Ariella Kelman
Contemporary Clinical Trials|July 23, 2019
Relocation of study participants for rare and ultra-rare disease trials: Ethics and operationsLuke Gelinas, Brian Crawford, Ariella Kelman, et al.
Blood|November 25, 2010
Pregnancy outcomes after maternal exposure to rituximabEliza F Chakravarty, Elaine R Murray, Ariella Kelman, et al.
Patient Preference and Adherence|December 24, 2016
Communicating laboratory test results for rheumatoid factor: what do patients and physicians want?Ariella Kelman, Caroline O Robinson, Elisenda Cochin, et al.
The Journal of Rheumatology|May 23, 2007
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the handsMolly D Magnano, Eliza F Chakravarty, Corrie Broudy, et al.
RMD Open|June 3, 2016
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumabAndrea Rubbert-Roth, Anthony Sebba, Laura Brockwell, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2017
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid ArthritisMark C Genovese, Joel M Kremer, Ronald F van Vollenhoven, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Rheumatology Reports|January 10, 2004
Outcome measures in osteoarthritis: randomized controlled trialsVibeke Strand, Ariella Kelman
Best Practice & Research. Clinical Rheumatology|November 23, 2005
The management of secondary osteoporosisAriella Kelman, Nancy E Lane
Arthritis Research & Therapy|August 23, 2003
A review of anabolic therapies for osteoporosisNancy E Lane, Ariella Kelman
Contemporary Clinical Trials|July 23, 2019
Relocation of study participants for rare and ultra-rare disease trials: Ethics and operationsLuke Gelinas, Brian Crawford, Ariella Kelman, et al.
Blood|November 25, 2010
Pregnancy outcomes after maternal exposure to rituximabEliza F Chakravarty, Elaine R Murray, Ariella Kelman, et al.
Patient Preference and Adherence|December 24, 2016
Communicating laboratory test results for rheumatoid factor: what do patients and physicians want?Ariella Kelman, Caroline O Robinson, Elisenda Cochin, et al.
The Journal of Rheumatology|May 23, 2007
A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the handsMolly D Magnano, Eliza F Chakravarty, Corrie Broudy, et al.
RMD Open|June 3, 2016
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumabAndrea Rubbert-Roth, Anthony Sebba, Laura Brockwell, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2017
Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid ArthritisMark C Genovese, Joel M Kremer, Ronald F van Vollenhoven, et al.
Pageof 2